Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study

E Ge, Y Li, S Wu, E Candido, X Wei - PLoS One, 2021 - journals.plos.org
Background The novel coronavirus disease 2019 (COVID-19) has infected 1.9% of the world
population by May 2, 2021. Since most previous studies that examined risk factors for …

Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis

SL Harrison, E Fazio-Eynullayeva, DA Lane… - PLoS …, 2020 - journals.plos.org
Background At the beginning of June 2020, there were nearly 7 million reported cases of
coronavirus disease 2019 (COVID-19) worldwide and over 400,000 deaths in people with …

A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19

B Thakur, P Dubey, J Benitez, JP Torres, S Reddy… - Scientific reports, 2021 - nature.com
Several comorbidities have been shown to be associated with coronavirus disease 2019
(COVID-19) related severity and mortality. However, considerable variation in the …

Unusually high risks of COVID-19 mortality with age-related comorbidities: An adjusted meta-analysis method to improve the risk assessment of mortality using the …

A Antos, ML Kwong, T Balmorez, A Villanueva… - Infectious disease …, 2021 - mdpi.com
Background: The pandemic of Coronavirus Disease 2019 (COVID-19) has been a threat to
global health. In the US, the Centers for Disease Control and Prevention (CDC) has listed 12 …

Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature

KT Bajgain, S Badal, BB Bajgain, MJ Santana - American journal of …, 2021 - Elsevier
Introduction On February 11, 2020 WHO designated the name “COVID-19” for the disease
caused by “severe acute respiratory syndrome coronavirus 2”(SARS-CoV-2), a novel virus …

Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

W Guan, W Liang, Y Zhao, H Liang… - European …, 2020 - Eur Respiratory Soc
Background The coronavirus disease 2019 (COVID-19) outbreak is evolving rapidly
worldwide. Objective To evaluate the risk of serious adverse outcomes in patients with …

Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis

P Ssentongo, AE Ssentongo, ES Heilbrunn, DM Ba… - PloS one, 2020 - journals.plos.org
Background Estimating the risk of pre-existing comorbidities on coronavirus disease 2019
(COVID-19) mortality may promote the importance of targeting populations at risk to improve …

History of coronary heart disease increased the mortality rate of patients with COVID-19: a nested case–control study

T Gu, Q Chu, Z Yu, B Fa, A Li, L Xu, R Wu, Y He - BMJ open, 2020 - bmjopen.bmj.com
Objective Evaluate the risk of pre-existing comorbidities on COVID-19 mortality, and provide
clinical suggestions accordingly. Setting A nested case–control design using confirmed case …

Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies …

K Dorjee, H Kim, E Bonomo, R Dolma - PloS one, 2020 - journals.plos.org
Introduction Progression of COVID-19 to severe disease and death is insufficiently
understood. Objective Summarize the prevalence of risk factors and adverse outcomes and …

[HTML][HTML] Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis

Y Zhou, Q Yang, J Chi, B Dong, W Lv, L Shen… - International Journal of …, 2020 - Elsevier
Objectives Existing findings regarding the relationship between comorbidities and the
severity of coronavirus disease 2019 (COVID-19) are inconsistent and insufficient. The aim …